156 related articles for article (PubMed ID: 3698174)
1. Altered pharmacokinetics in the mechanism of chemosensitization: effects of nitroimidazoles and other chemical modifiers on the pharmacokinetics, antitumour activity and acute toxicity of selected nitrogen mustards.
Lee FY; Workman P
Cancer Chemother Pharmacol; 1986; 17(1):30-7. PubMed ID: 3698174
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic basis for the comparative antitumour activity and toxicity of chlorambucil, phenylacetic acid mustard and beta, beta-difluorochlorambucil (CB 7103) in mice.
Lee FY; Coe P; Workman P
Cancer Chemother Pharmacol; 1986; 17(1):21-9. PubMed ID: 3698173
[TBL] [Abstract][Full Text] [Related]
3. Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU.
Workman P; Twentyman PR
Br J Cancer; 1982 Aug; 46(2):249-59. PubMed ID: 7150475
[TBL] [Abstract][Full Text] [Related]
4. Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.
Lee FY; Workman P
Br J Cancer; 1983 May; 47(5):659-69. PubMed ID: 6849803
[TBL] [Abstract][Full Text] [Related]
5. Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
Twentyman P; Workman P
Br J Cancer; 1982 Mar; 45(3):447-55. PubMed ID: 7073938
[TBL] [Abstract][Full Text] [Related]
6. Chemosensitization by lipophilic nitroimidazoles.
Twentyman PR; Workman P
Br J Cancer; 1983 Jul; 48(1):17-26. PubMed ID: 6871076
[TBL] [Abstract][Full Text] [Related]
7. An investigation of the possibility of chemosensitization by clinically achievable concentrations of misonidazole.
Twentyman PR; Workman P
Br J Cancer; 1983 Feb; 47(2):187-94. PubMed ID: 6824566
[TBL] [Abstract][Full Text] [Related]
8. Enhancement by electron-affinic agents of the therapeutic effects of cytotoxic agents against the KHT tumor: structure-activity relationships.
Workman P; Twentyman PR
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):623-6. PubMed ID: 7107385
[TBL] [Abstract][Full Text] [Related]
9. Misonidazole and CCNU: further evidence for a pharmacokinetic mechanism of chemosensitization and therapeutic gain.
Lee FY; Workman P
Br J Cancer; 1984 May; 49(5):579-85. PubMed ID: 6722006
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of the DNA cross-linking activity of melphalan by misonidazole in vivo.
Murray D; Meyn RE
Br J Cancer; 1983 Feb; 47(2):195-203. PubMed ID: 6824567
[TBL] [Abstract][Full Text] [Related]
11. Misonidazole and benznidazole inhibit hydroxylation of CCNU by mouse liver microsomal cytochrome P-450 in vitro.
Lee FY; Workman P; Cheeseman KH
Biochem Pharmacol; 1987 Apr; 36(8):1349-55. PubMed ID: 3593422
[TBL] [Abstract][Full Text] [Related]
12. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
Siemann DW
Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
[TBL] [Abstract][Full Text] [Related]
13. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
Mulcahy RT; Siemann DW
Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
[TBL] [Abstract][Full Text] [Related]
14. Nitroimidazoles as modifiers of nitrosourea pharmacokinetics.
Lee FY; Workman P
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1627-30. PubMed ID: 6237080
[TBL] [Abstract][Full Text] [Related]
15. The effect of radiosensitizers on the pharmacokinetics of melphalan and cyclophosphamide in the mouse.
Hinchliffe M; McNally NJ; Stratford MR
Br J Cancer; 1983 Sep; 48(3):375-83. PubMed ID: 6615699
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of thermoradiosensitization by misonidazole and metronidazole in vivo: antitumour effect and pharmacokinetics.
Wong KH; Maezawa H; Urano M
Int J Hyperthermia; 1992; 8(5):645-58. PubMed ID: 1402141
[TBL] [Abstract][Full Text] [Related]
17. Misonidazole protects mouse tumour and normal tissues from the toxicity of oral CCNU.
Lee FY; Workman P
Br J Cancer; 1985 Jan; 51(1):85-91. PubMed ID: 3966974
[TBL] [Abstract][Full Text] [Related]
18. The effect of radiosensitizer pretreatment on the response of the RIF-1 mouse sarcoma to cytotoxic drugs.
Twentyman PR; Workman P
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):611-3. PubMed ID: 7107382
[TBL] [Abstract][Full Text] [Related]
19. Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.
Twentyman PR
Br J Cancer; 1981 Jun; 43(6):745-55. PubMed ID: 6264941
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of melphalan activity in the KHT sarcoma by the radiosensitizer RSU 1069.
Siemann DW; Maddison K; Wolf K
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1657-60. PubMed ID: 6548212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
